Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

Drug disposition is highly regulated by membrane transporters. Some transporter-mediated drug–drug interactions (DDIs) may not manifest themselves in changes in systemic exposure but rather in changes in tissue exposure of drugs. To better assess the impact of transporter-mediated DDIs in tissues, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wulkersdorfer, B, Wanek, T, Bauer, M, Zeitlinger, M, Müller, M, Langer, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153445/
https://www.ncbi.nlm.nih.gov/pubmed/24682030
http://dx.doi.org/10.1038/clpt.2014.70
Descripción
Sumario:Drug disposition is highly regulated by membrane transporters. Some transporter-mediated drug–drug interactions (DDIs) may not manifest themselves in changes in systemic exposure but rather in changes in tissue exposure of drugs. To better assess the impact of transporter-mediated DDIs in tissues, positron emission tomography (PET)—a noninvasive imaging method—plays an increasingly important role. In this article, we provide examples of how PET can be used to assess transporter-mediated DDIs in different organs.

Ejemplares similares